About: Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 2014

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 2014 (uk) article scientifique publié en 2014 (fr) artículu científicu espublizáu en febreru de 2014 (ast) artikull shkencor i botuar më 01 shkurt 2014 (sq) scientific article published on 01 February 2014 (en)
publication date	wds:Q86800012-A805EFD5-4CD5-4C6D-B3D5-6F4522E0A80A
publication date	2014-02-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q86800012-005987F6-9A30-4EFC-B732-476D98A4C8C0 wds:Q86800012-35523D90-626F-461E-B0B6-3BB742095032 wds:Q86800012-363D5D04-06FA-4DA7-9462-F167B0EC0F77 wds:Q86800012-3D4E1C8D-A328-4AEA-AEFF-6CA2FD458466 wds:Q86800012-6100A5CA-327E-4762-85DC-972AC13E11AA wds:Q86800012-73336C26-8E74-4E38-B892-073B84BCB248 wds:Q86800012-788FE404-7078-43C9-9B95-EA0966710538 wds:Q86800012-A4FB305E-FF5D-4E3C-A14C-41965E4C5354 wds:Q86800012-A5D5954D-8A0E-48AC-BC4D-0C8AB8D4487D wds:Q86800012-C99D0984-1A0B-43FE-A8E6-8CBE06CA850B
author name string	Bo Li Beibei Luo Yun Zhang Cheng Zhang Xiaoman Liu Mingxiang Zhang Yanfei Xia Wenke Wang Fengshuang An Xiangjuan Liu
rdfs:label	Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (en) Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (nl) Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (sq)
skos:prefLabel	Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (en) Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (nl) Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (sq)
name	Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (en) Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (nl) Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (sq)
title	wds:Q86800012-0126DF8E-724B-4648-8779-CA0DE0D9267C
title	Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model (en)
page(s)	wds:Q86800012-C652BD4A-419D-4673-A816-998BD35A19F1
page(s)	33-43
instance of	wds:Q86800012-E2EED272-9FAE-40F6-A9C8-94E62CE85679
instance of	scholarly article
main subject	wds:Q86800012-301F931E-EA3E-4241-A1D5-2D3E9425A734 wds:Q86800012-C1417917-50C4-46C2-87A0-D0D1C83C0B5F wds:Q86800012-FAFB2232-0EA9-45B7-BA53-8D73B7D3A3B6
main subject	diabetic cardiomyopathy type 2 diabetes cardiomyopathy
PubMed ID	wds:Q86800012-F9CFE37F-3FE6-489F-891E-3BA4ECE9B879
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24254031
PubMed ID	24254031
published in	wds:Q86800012-FD99193F-6EC3-48E1-A9E4-173920521072
published in	Cardiovascular Drugs and Therapy
issue	wds:Q86800012-FC4E7753-8C63-49C6-8DEC-B03E9EF76081
volume	wds:Q86800012-EEC16A41-FE3B-4361-8474-DB00230D122A
issue	1
volume	28
DOI	wds:Q86800012-87189122-8668-403D-AFF7-1560DC1D1394
DOI	http://dx.doi.org/10.1007/S10557-013-6498-1
DOI	10.1007/S10557-013-6498-1
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q86800012
is cites work of	Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage Targeting metabolic disturbance in the diabetic heart Circulating interleukin-1β promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2 Resveratrol alleviates vascular inflammatory injury by inhibiting inflammasome activation in rats with hypercholesterolemia and vitamin D2 treatment IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit. Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects. Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy. NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy. NLRP3 Inflammasome Expression and Signaling in Human Diabetic Wounds and in High Glucose Induced Macrophages. Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications. Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes. A Novel Circular RNA Mediates Pyroptosis of Diabetic Cardiomyopathy by Functioning as a Competing Endogenous RNA Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy Role of pyroptosis in cardiovascular disease Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases. Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats Exercise Training Promotes Cardiac Hydrogen Sulfide Biosynthesis and Mitigates Pyroptosis to Prevent High-Fat Diet-Induced Diabetic Cardiomyopathy Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation NLRP3 inflammasome, an immune-inflammatory target in pathogenesis and treatment of cardiovascular diseases Astragaloside IV Suppresses High Glucose-Induced NLRP3 Inflammasome Activation by Inhibiting TLR4/NF-B and CaSR Ropivacaine Prevents the Activation of the NLRP3 Inflammasome Caused by High Glucose in HUVECs Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events? Baicalein, as a Prooxidant, Triggers Mitochondrial Apoptosis in MCF-7 Human Breast Cancer Cells Through Mobilization of Intracellular Copper and Reactive Oxygen Species Generation Mitochondrial Contact Sites in Inflammation-Induced Cardiovascular Disease Functional Implications of HMG-CoA Reductase Inhibition on Glucose Metabolism
is cites work of	wds:Q26770744-C9B6D397-55D2-4140-91BC-0145775FD132 wds:Q39403443-73F49027-2A7D-499C-94AF-FDA289BBAA2F wds:Q42702119-504D427A-36B2-4EA3-BB2A-9D6C3EDC7596 wds:Q47739163-64252D06-3A6E-4381-A397-0D06244B1E52 wds:Q89811716-52351597-90E0-4EF7-B106-0AA5D9D590D1 wds:Q35084845-43792F2F-2117-4713-B9C0-0C569286C126 wds:Q92541234-00974969-E79B-4349-BA2E-7CD22525E27E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software